{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:33:19Z","timestamp":1792762399321,"version":"4.5.0"},"reference-count":48,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1001\/jamapsychiatry.2018.3537","type":"journal-article","created":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T14:06:18Z","timestamp":1545228378000},"page":"127","source":"Crossref","is-referenced-by-count":61,"title":["Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone"],"prefix":"10.1001","volume":"76","author":[{"given":"Zill-e-Huma","family":"Latif","sequence":"first","affiliation":[{"name":"Department of Research and Development in Mental Health, Akershus University Hospital, L\u00f8renskog, Norway"},{"name":"Norwegian Center for Addiction Research, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurate","family":"\u0160altyte Benth","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, Campus Ahus, University of Oslo, Oslo, Norway"},{"name":"Health Services Research Unit, Akershus University Hospital, L\u00f8renskog, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin Klemmetsby","family":"Solli","sequence":"additional","affiliation":[{"name":"Department of Research and Development in Mental Health, Akershus University Hospital, L\u00f8renskog, Norway"},{"name":"Norwegian Center for Addiction Research, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arild","family":"Opheim","sequence":"additional","affiliation":[{"name":"Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway"},{"name":"Faculty of Medicine and Odonthology, The University of Bergen, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaj","family":"Kunoe","sequence":"additional","affiliation":[{"name":"Department of Research and Development in Mental Health, Akershus University Hospital, L\u00f8renskog, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Krajci","sequence":"additional","affiliation":[{"name":"Department of Addiction Medicine, Oslo University Hospital, Oslo, Norway"},{"name":"Vestfold Hospital Trust, Toensberg, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamni","family":"Sharma-Haase","sequence":"additional","affiliation":[{"name":"Norwegian Center for Addiction Research, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Tanum","sequence":"additional","affiliation":[{"name":"Department of Research and Development in Mental Health, Akershus University Hospital, L\u00f8renskog, Norway"},{"name":"Norwegian Center for Addiction Research, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"yoi180087r1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000067732","article-title":"Gender differences in the prevalence of symptom disorders and personality disorders among poly-substance abusers and pure alcoholics: substance abusers treated in two counties in Norway.","volume":"9","author":"Landheim","year":"2003","journal-title":"Eur Addict Res"},{"key":"yoi180087r2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000085910","author":"Hintz","year":"2005","journal-title":"Dual Diagnosis: The Evolving Conceptual Framework"},{"issue":"19","key":"yoi180087r3","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","article-title":"Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) Study.","volume":"264","author":"Regier","year":"1990","journal-title":"JAMA"},{"issue":"4","key":"yoi180087r4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0733-8619(05)70283-8","article-title":"Sleep in psychiatric disorders.","volume":"14","author":"Benca","year":"1996","journal-title":"Neurol Clin"},{"issue":"8","key":"yoi180087r5","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1001\/archpsyc.1992.01820080059010","article-title":"Sleep and psychiatric disorders: a meta-analysis.","volume":"49","author":"Benca","year":"1992","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"yoi180087r6","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1001\/archpsyc.61.8.807","article-title":"Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.","volume":"61","author":"Grant","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"yoi180087r7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/(ISSN)1520-6394","article-title":"Comorbidity of mood and anxiety disorders.","volume":"12","author":"Kaufman","year":"2000","journal-title":"Depress Anxiety"},{"issue":"1","key":"yoi180087r8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/archpsyc.1997.01830130077015","article-title":"Psychiatric and substance use comorbidity among treatment-seeking opioid abusers.","volume":"54","author":"Brooner","year":"1997","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"yoi180087r9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1001\/archpsyc.1982.04290020021004","article-title":"Diagnosis and symptoms of depression in opiate addicts: course and relationship to treatment outcome.","volume":"39","author":"Rounsaville","year":"1982","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"yoi180087r10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1515\/nsad-2015-0048","article-title":"Rusmisbruk, angst og depresjon etter 10 \u00e5r: en prospektiv unders\u00f8kelse av stoffmisbrukere med og uten LAR-behandling.","volume":"32","author":"Ravndal","year":"2015","journal-title":"Nordic Stud Alcohol and Drugs"},{"issue":"1","key":"yoi180087r11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000081412","article-title":"Significance of comorbidity for the long-term course of opiate dependence.","volume":"11","author":"Verthein","year":"2005","journal-title":"Eur Addict Res"},{"issue":"6","key":"yoi180087r12","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/BF02922262","article-title":"The 2-year course following detoxification treatment of substance abuse: the possible influence of psychiatric comorbidity.","volume":"247","author":"T\u00f3masson","year":"1997","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"2","key":"yoi180087r14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s001270170066","article-title":"Severely mentally ill substance abusers: an 18-month follow-up study.","volume":"36","author":"Schaar","year":"2001","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"2","key":"yoi180087r15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0740-5472(96)00131-6","article-title":"The course of depressive symptoms over time for women who completed drug treatment.","volume":"14","author":"Nishimoto","year":"1997","journal-title":"J Subst Abuse Treat"},{"issue":"5","key":"yoi180087r16","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/sleep\/34.5.601","article-title":"The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response.","volume":"34","author":"Morin","year":"2011","journal-title":"Sleep"},{"issue":"3","key":"yoi180087r17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0740-5472(03)00191-0","article-title":"Sleep disturbances among methadone maintained patients.","volume":"26","author":"Stein","year":"2004","journal-title":"J Subst Abuse Treat"},{"issue":"9","key":"yoi180087r18","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1111\/add.2013.108.issue-9","article-title":"Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness.","volume":"108","author":"Krupitsky","year":"2013","journal-title":"Addiction"},{"issue":"2","key":"yoi180087r19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1001\/archpsyc.63.2.210","article-title":"Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial.","volume":"63","author":"Comer","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"yoi180087r20","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1001\/jamapsychiatry.2017.3206","article-title":"Effectiveness of injectable extended-release naltrexone vs daily buprenorphine-naloxone for opioid dependence: a randomized clinical noninferiority trial.","volume":"74","author":"Tanum","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"10118","key":"yoi180087r21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.","volume":"391","author":"Lee","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"yoi180087r22","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1176\/ajp.111.5.343","article-title":"Comfort, effectiveness, and self-awareness as criteria of improvement in psychotherapy.","volume":"111","author":"Parloff","year":"1954","journal-title":"Am J Psychiatry"},{"issue":"1","key":"yoi180087r23","first-page":"6","article-title":"Psychiatric illness in family practice.","volume":"41","author":"Hesbacher","year":"1980","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"yoi180087r24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1192\/bjp.144.4.395","article-title":"Symptoms of emotional distress in a family planning service: stability over a four-week period.","volume":"144","author":"Winokur","year":"1984","journal-title":"Br J Psychiatry"},{"issue":"8","key":"yoi180087r25","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1176\/ajp.128.8.1005","article-title":"Evaluating clinical improvement in anxious outpatients: a comparison of normal and treated neurotic patients.","volume":"128","author":"Rickels","year":"1972","journal-title":"Am J Psychiatry"},{"issue":"7","key":"yoi180087r26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s001270050064","article-title":"Concordance between symptom screening and diagnostic procedure: the Hopkins Symptom Checklist-25 and the Composite International Diagnostic Interview I.","volume":"33","author":"Sandanger","year":"1998","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"4","key":"yoi180087r27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1389-9457(00)00065-4","article-title":"Validation of the Insomnia Severity Index as an outcome measure for insomnia research.","volume":"2","author":"Bastien","year":"2001","journal-title":"Sleep Med"},{"key":"yoi180087r28","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"yoi180087r29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40360-016-0061-1","article-title":"Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX).","volume":"17","author":"Kun\u00f8e","year":"2016","journal-title":"BMC Pharmacol Toxicol"},{"issue":"2","key":"yoi180087r30","first-page":"106","article-title":"Long-term opioid blockade and hedonic response: preliminary data from two open-label extension studies with extended-release naltrexone.","volume":"20","author":"O\u2019Brien","year":"2011","journal-title":"Am J Addict"},{"issue":"6","key":"yoi180087r31","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1080\/17470919.2015.1136355","article-title":"Naltrexone alters the processing of social and emotional stimuli in healthy adults.","volume":"11","author":"Wardle","year":"2016","journal-title":"Soc Neurosci"},{"issue":"5","key":"yoi180087r32","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1080\/00952990.2016.1197231","article-title":"Anhedonia, depression, anxiety, and craving in opiate dependent patients stabilized on oral naltrexone or an extended release naltrexone implant.","volume":"42","author":"Krupitsky","year":"2016","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2","key":"yoi180087r33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/10550490290087929","article-title":"Naltrexone and dysphoria: fact or myth?","volume":"11","author":"Miotto","year":"2002","journal-title":"Am J Addict"},{"issue":"14","key":"yoi180087r34","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1007\/s00213-015-3891-4","article-title":"Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients.","volume":"232","author":"Zaaijer","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"yoi180087r35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3109\/00952990.2010.540281","article-title":"The association between naltrexone treatment and symptoms of depression in opioid-dependent patients.","volume":"37","author":"Mysels","year":"2011","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"1","key":"yoi180087r36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1139\/jpn.0605","article-title":"Does naltrexone treatment lead to depression? findings from a randomized controlled trial in subjects with opioid dependence.","volume":"31","author":"Dean","year":"2006","journal-title":"J Psychiatry Neurosci"},{"key":"yoi180087r37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.05.031","article-title":"Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990-2014: a systematic review and meta-analysis.","volume":"154","author":"Lai","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"yoi180087r38","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1192\/bjp.bp.108.055319","article-title":"Naltrexone implants after in-patient treatment for opioid dependence: randomised controlled trial.","volume":"194","author":"Kun\u00f8e","year":"2009","journal-title":"Br J Psychiatry"},{"issue":"10","key":"yoi180087r39","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1001\/archgenpsychiatry.2009.130","article-title":"Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone.","volume":"66","author":"Hulse","year":"2009","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"yoi180087r40","first-page":"7","article-title":"Changes in psychosocial symptoms of opiate users over six months with buprenorphine\/naloxone substitution therapy","volume":"14","author":"Petke","year":"2012","journal-title":"Neuropsychopharmacol Hung"},{"issue":"1","key":"yoi180087r41","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1152\/physrev.2001.81.1.299","article-title":"Cellular and synaptic adaptations mediating opioid dependence.","volume":"81","author":"Williams","year":"2001","journal-title":"Physiol Rev"},{"issue":"1","key":"yoi180087r42","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00004714-199502000-00008","article-title":"Buprenorphine treatment of refractory depression.","volume":"15","author":"Bodkin","year":"1995","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"yoi180087r43","first-page":"1009","article-title":"Self-reported sleep improvement in buprenorphine MAT (Medication Assisted Treatment) population.","volume":"3","author":"Zheng","year":"2016","journal-title":"Austin J Drug Abuse Addict"},{"issue":"1","key":"yoi180087r44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jsat.2010.03.014","article-title":"Self-treatment: illicit buprenorphine use by opioid-dependent treatment seekers.","volume":"39","author":"Schuman-Olivier","year":"2010","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"yoi180087r45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1053\/smrv.2002.0186","article-title":"Epidemiology of insomnia: what we know and what we still need to learn.","volume":"6","author":"Ohayon","year":"2002","journal-title":"Sleep Med Rev"},{"issue":"11","key":"yoi180087r46","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1001\/jama.1989.03430110069030","article-title":"Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention?","volume":"262","author":"Ford","year":"1989","journal-title":"JAMA"},{"issue":"4","key":"yoi180087r47","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1037\/1064-1297.4.4.413","article-title":"Reversal of sleep disturbances in cocaine-and heroin-dependent men during chronic buprenorphine treatment.","volume":"4","author":"Lukas","year":"1996","journal-title":"Exp Clin Psychopharmacol"},{"issue":"5","key":"yoi180087r48","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJM199701303360506","article-title":"Management of insomnia.","volume":"336","author":"Kupfer","year":"1997","journal-title":"N Engl J Med"},{"key":"yoi180087r13","volume-title":"The Process of Recovery Among Severely Mentally Ill Substance Abusers: A Long-term Follow-up of a Multicentre Study in Connection With the Psychiatric Care Reform Initiated by the Department of Social Affairs","author":"\u00d6jehagen","year":"2004"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2718627","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T16:55:46Z","timestamp":1775321746000},"score":1,"resource":{"primary":{"URL":"http:\/\/archpsyc.jamanetwork.com\/article.aspx?doi=10.1001\/jamapsychiatry.2018.3537"}},"subtitle":["A Randomized Clinical Trial and Follow-up Study"],"short-title":[],"issued":{"date-parts":[[2019,2,1]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2018.3537","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2,1]]}}}